U

Umoja Biopharma

In vivo CAR T-cell cancer therapy

Vice President - Head of Portfolio & Program Strategy

Program ManagementConfirmed live in the last 24 hours
Full-timeSeattle, WA, USA$293k - $362k

About the Job

Requirements

  • A bachelor's degree in a scientific, business, engineering, or related field and 15 or more years of biotechnology or pharmaceutical industry experience with increasing responsibility in portfolio strategy, program management, program leadership, or R&D leadership.
  • Demonstrated senior leadership experience in portfolio management, program leadership, or a closely related discipline.
  • Deep understanding of the end-to-end drug development process and the cross-functional interdependencies needed to advance complex programs from early clinical development toward later-stage development and commercialization.
  • A track record of leading programs through clinical development, including late-stage or commercialization experience.
  • Proven success leading cross-functional teams and portfolio processes in a growing biotechnology or pharmaceutical organization.
  • Ability to translate strategy, data, risks, and competing functional inputs into integrated plans, clear choices, and decision-ready recommendations.
  • Strength in portfolio prioritization, risk management, scenario planning, governance, resource planning, and organizational change.
  • Leadership and coaching capability, including experience building and developing high-performing program and project management talent.
  • Executive presence and communication skills, including the ability to influence without authority, build trust, challenge constructively, and align stakeholders across organizational levels.
  • Ability to move effectively between enterprise-level strategic questions and detailed program execution.
  • Ability to work onsite at least three days per week in the Seattle office.
  • Ability to perform the essential functions of an office-based leadership role, including participating in in-person and virtual meetings, with or without reasonable accommodation.
  • Ability to travel periodically between company locations and to external business meetings as needed.

Responsibilities

  • Drive enterprise-level portfolio strategy in alignment with scientific, clinical, operational, and commercial objectives.
  • Lead portfolio prioritization, trade-off, and investment discussions to support effective resource allocation across programs.
  • Establish and maintain an enterprise-level portfolio view communicating program status, critical paths, stage gates, decision points, risks, opportunities, and resource implications.
  • Build and institutionalize portfolio analytics, scenario planning, and risk assessment processes to support executive decision-making.
  • Translate complex scientific, clinical, operational, and financial inputs into clear scenarios and actionable recommendations.
  • Ensure alignment and integration across R&D, Clinical Development, Clinical Operations, CMC/Technical Operations, Regulatory, Quality, Translational Medicine, Medical Affairs, Finance, and other enabling functions.
  • Establish, lead, and continually evolve the company's Portfolio and Program Management function as an organizational capability.
  • Lead cross-functional portfolio and program planning and execution, ensuring teams operate with clear objectives, integrated timelines, defined milestones, dependencies, and accountabilities.
  • Partner with program and functional leaders to develop and maintain integrated development plans, timelines, budgets, and resource requirements.
  • Define and establish consistent standards, tools, and processes for program planning, execution, and reporting across the organization.
  • Ensure integrated project plans reflect cross-functional dependencies, critical paths, major decision points, and key development milestones.
  • Partner with functional leaders to track timelines, budgets, milestones, risks, and resource requirements transparently at program and portfolio levels.
  • Balance urgency and ambition with realistic, credible, and executable program plans.
  • Identify portfolio and program risks early and lead cross-functional development of mitigation and contingency plans.
  • Escalate material risks and issues at the appropriate time with clear implications, options, and practical recommendations.
  • Drive integrated resource and capacity planning across programs, identifying constraints, dependencies, investment choices, and potential impacts to portfolio timelines and value.
  • Support leadership in evaluating resource trade-offs and prioritization decisions across the portfolio.
  • Maintain portfolio-level risk registers and mechanisms for monitoring mitigation activities and emerging risks.
  • Establish and manage governance forums supporting portfolio decision-making and program oversight.
  • Develop governance practices that enable timely escalation, focused leadership discussions, clear decision rights, durable decisions, and disciplined follow-through.
  • Create decision-ready materials framing key issues, alternatives, risks, implications, and recommendations.
  • Establish standardized portfolio dashboards, decision logs, risk registers, and reporting frameworks that provide reliable sources of truth for leadership and program teams.
  • Deliver clear, data-driven portfolio and program updates to senior leadership and the Board of Directors when required.
  • Promote transparency, accountability, and alignment through consistent governance and communication practices.
  • Recruit, lead, coach, and develop a high-performing team of program and project leaders capable of supporting the portfolio from development through commercialization.
  • Empower program leaders to drive accountability, decision-making, and execution within cross-functional teams.
  • Establish common expectations, capabilities, and ways of working across the Portfolio and Program Management organization.
  • Foster a culture of transparency, collaboration, constructive challenge, accountability, and enterprise-first decision-making.
  • Build scalable organizational capabilities, including portfolio management tools, dashboards, governance systems, and Portfolio and Program Management infrastructure.
  • Anticipate future capabilities, operating model, and organizational changes in partnership with senior leadership and HR as required, enabling the company to advance programs toward later-stage development and commercialization.
  • Serve as a culture carrier for collaboration, operational discipline, and delivery excellence.
  • Lead portfolio-wide input into annual operating plans, long-range planning, and corporate strategy.
  • Integrate portfolio priorities, program plans, resource requirements, risks, and key assumptions into company planning.
  • Provide senior leadership with transparent assessments of portfolio scenarios and trade-offs to enable enterprise-level decision-making.
  • Contribute as a senior leadership team member to enterprise decision-making beyond the Portfolio and Program Management remit.

Desired Qualifications

  • An advanced degree in life sciences, medicine, business, or a related discipline, such as a PhD, PharmD, MD, or MBA.
  • Experience scaling a Portfolio and Program Management function within a growth-stage biotechnology company.
  • Experience helping an organization progress from early clinical development toward later-stage development and commercialization readiness.
  • Experience building or materially expanding a Portfolio and Program Management operating model, including governance frameworks and enterprise portfolio reporting.
  • Proficiency with modern portfolio and program management tools and development of practical, executive-level portfolio dashboards.

About the Company

Umoja Biopharma

In vivo CAR T-cell cancer therapy

Umoja Biopharma develops immunotherapies that reprogram patients’ T cells inside the body (in vivo) to attack cancer. Its main product approach is a CAR T-cell gene therapy platform designed to be produced in-house and sold as off-the-shelf regimens, enabling scalable treatment for both solid tumors and blood cancers that have not responded to other therapies. The treatment works by modifying the patient’s immune system directly in the body to create CAR T cells that can target and kill cancer cells, aiming for lasting remissions. Unlike many therapies that extract cells from a patient, modify them outside the body, and then reinsert them, Umoja Biopharma focuses on in-body cell reprogramming and in-house manufacturing to streamline delivery. The company differentiates itself through its in vivo, off-the-shelf CAR T approach and its goal of broad applicability across cancer stages, seeking to provide accessible, scalable cancer treatments across solid and hematologic cancers.

Company size
201-500
Company stage
Series C
Total funding
$363M
Headquarters
Seattle, WA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Umoja Biopharma

See more jobs